Subscribe to eTOC

VIDEOS ON DEMAND
Is intra-arterial treatment for stroke a “game changer?”

Figure

No caption available.

Figure

No caption available.

Three clinical trials have now replicated the findings of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN) study, which was published in the Jan. 1 issue of the New England Journal of Medicine, supporting early endovascular removal of the stroke-causing clots as the new standard-of-care. The studies all showed that if patients with these major strokes were treated with tissue plasminogen activator (tPA) and embolectomy using image-guided stent retriever devices, their outcomes were superior to tPA therapy alone. In a video interview, Neurology Today Editor-in-chief Steven P. Ringel, MD, FAAN, and Associate Editor Robert G. Holloway Jr., MD, FAAN, discuss the impact the new findings could have on practice. Read the Neurology Today story here: http://bit.ly/NT-intra-arterial. Watch the Neurology Today video on our YouTube channel: http://bit.ly/intra-arterial-video.